Reporte zur Charge EUO177

Symptomtext

General soreness; Itchiness in arm; headache came on within hours, and was made far worse by exposure to bright light\sunlight.; This is a spontaneous report from a contactable consumer (patient). A 48-years-old non pregnant female patient reported for herself that she received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EUO177), via an unspecified route, administered in arm left on 16May2021 at 09:45 AM (age at vaccination was 48 years) as dose 2, single for covid-19 immunization at pharmacy or drug store. The patient was not pregnant at the time of vaccination. No other vaccines were received within four weeks prior to the administration of bnt162b2. Medical history included hashimoto, obesity and known allergy to trees, cats, dogs, ragweed; all from an unknown date and unknown if ongoing. Concomitant medications included levothyroxine sodium (SYNTHROID), phentermine (ADIPEX [PHENTERMINE]), metformin, hydrochlorothiazide (HYDRODIURIL), multivitamin; all taken in two weeks for an unspecified indication, start and stop date were not reported. The patient previously received bnt162b2 (Batch/Lot Number: EUO170), via an unspecified route, administered in arm left on 25Apr2021 (age at vaccination was 48 years) as dose 1, single for covid-19 immunization and experienced mild sore arm, mild headache. On 16May2021 at 01:15 PM, after the second injection, the patient's headache came on within hours and was made worse by exposure to bright light\sunlight. Staying in the dark was more effective than OTC unspecified pain medications. On 18May2021, the next 2 days, the patient experienced general soreness\itchiness in arm. No treatment was received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. Outcome of all events was recovered on an unspecified date in 2021. Follow-up attempts are completed. No further information is expected.